WeVote
Log In

Bill

Bill

HD 1361

An Act relative to the administration of anti-psychotic or other psychotropic substances to nursing home residents

194th Legislature (2025-2026) Introduced by Carmine Gentile and 1 co-sponsor

Massachusetts bill requiring enhanced oversight and documentation standards for psychotropic medication use in nursing homes to prevent inappropriate chemical restraint of residents.

0
WeVote Research Nonpartisan
Bill Summary · HD 1361

Legislative bill overview

HD 1361 establishes procedural and oversight requirements for administering anti-psychotic and other psychotropic medications to nursing home residents in Massachusetts. The bill creates standards for when and how these medications can be prescribed, monitored, and documented in long-term care facilities.

Why is this important

Nursing home residents, who are often elderly and vulnerable, have historically been over-medicated with psychotropic drugs as a form of behavioral control rather than genuine medical necessity—a practice known as "chemical restraint." This bill addresses patient safety and dignity by imposing oversight mechanisms that protect residents from unnecessary or inappropriate medication use while ensuring proper medical justification exists for prescriptions.

Potential points of contention

  • Prescribing restrictions vs. clinical autonomy: The bill may limit physician discretion in treatment decisions, or conversely, may not impose sufficiently strong restrictions if oversight mechanisms lack enforcement teeth
  • Staffing and compliance costs: Nursing homes may argue that new documentation, monitoring, and review requirements increase operational expenses without corresponding reimbursement
  • Definitional ambiguity: What qualifies as "appropriate" use of psychotropic medications and what triggers required interventions could be unclear, creating inconsistent implementation across facilities

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.